SIGNAFUSE Bioactive Bone Graft Receives FDA Clearance
The biphasic mineral in SIGNAFUSE is composed of 60% hydroxyapatite and 40% beta- tricalcium phosphate; a ratio supported by multiple prospective2 and randomized controlled trials.3-5
Affluent Medical Expands Leadership Team
The company appointed Jean-François Le Bigot and Benoit Adelus to the board. Michael Finance was also appointed to the board and elected as Chairman of the Board.
Affluent Medical Announces €15.8 Million in New Financing
The investment was led by Truffle Capital through the Truffle Biomedtech FCPI Fund and Truffle Innov FRR France and other investors
Thomas J. Garite, M.D. Appointed Vice President of Clinical Sciences at Sera Prognostics: World-Renowned & Highly Respected Expert
Dr. Garite will work closely with Sera to advance clinical development programs that support the company’s growth from development into a commercial-stage company.
Allegheny Health Network Ongoing Efforts to Ensure that Frontline Hospital Caregivers Are Protected to Help Prevent Exposure to COVID-19 and Other Infectious Diseases
The protective barrier enclosure is produced by Magee Plastics and consists of a transparent plastic cube designed to cover a patient's head while they are in a hospital bed.